PE anti-human CD38 [HB-7] and 2 more items

BioLegend Inc. was awarded a contract by the University of Virginia on August 8, 2026, for the supply of specialized flow cytometry reagents and antibodies. The contract, identified as A207_PO-0466986, is valued at six hundred fifty-two dollars ($652.00) and encompasses three distinct line items to be delivered to Abhinav Arneja. The products include PE (phycoerythrin) anti-human CD38 [HB-7] monoclonal antibody at $165.90, Brilliant Violet 421a anti-human CD19 [SJ25C1] monoclonal antibody at $301.50, and Alexa Fluor 647 anti-human CD27 [M-T271] monoclonal antibody at $185.50.

These flow cytometry reagents are essential laboratory products used in immunophenotyping and cell analysis applications within research or clinical settings. The award represents a straightforward procurement of one unit each of specialized immunological markers targeting specific human cell surface antigens (CD38, CD19, and CD27), which are commonly employed in hematologic and immunologic research at academic medical institutions. The contract was awarded to the prime contractor BioLegend Inc., a recognized supplier of life science research reagents, with performance under the contracting organization of the University of Virginia in Virginia.